Article Text

Download PDFPDF
A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer
  1. C Cybulski1,
  2. D Wokołorczyk1,
  3. T Huzarski1,
  4. T Byrski1,
  5. J Gronwald1,
  6. B Górski1,
  7. T Dębniak1,
  8. B Masojć1,
  9. A Jakubowska1,
  10. B Gliniewicz2,
  11. A Sikorski2,
  12. M Stawicka3,
  13. D Godlewski3,
  14. Z Kwias4,
  15. A Antczak4,
  16. K Krajka5,
  17. W Lauer5,
  18. M Sosnowski6,
  19. P Sikorska-Radek7,
  20. K Bar8,
  21. R Klijer8,
  22. R Zdrojowy9,
  23. B Małkiewicz9,
  24. A Borkowski10,
  25. T Borkowski10,
  26. M Szwiec11,
  27. S A Narod12,
  28. J Lubiński1
  1. 1International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
  2. 2Clinic of Urology, Pomeranian Medical University, Szczecin
  3. 3Cancer Prevention and Epidemiology Center, Poznan, Poland
  4. 4Clinic of Urology, Medical Academy, Poznan
  5. 5Clinic of Urology, Medical Academy, Gdansk, Poland
  6. 6Clinic of Urology, Medical Academy, Łódź, Poland
  7. 7Clinic of Urology Regional Hospital, Łódź
  8. 8Clinic of Urology, Medical Academy, Lublin, Poland
  9. 9Clinic of Urology, Medical Academy, Wrocław, Poland
  10. 10Clinic of Urology, Medical Academy, Warszawa, Poland
  11. 11Regional Oncology Hospital, Olsztyn, Poland
  12. 12Centre for Research on Women’s Health, Toronto, Ontario, Canada
  1. Correspondence to:
 C Cybulski
 Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, ul Połabska 4, 70-115 Szczecin, Poland; cezarycy{at}sci.pam.szczecin.pl

Footnotes

  • Competing interests: None.

  • Ethical approval: This study was approved by the Ethics Committee of Pomeranian Medical University, Szczecin, Poland.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Ethical approval: This study was approved by the Ethics Committee of Pomeranian Medical University, Szczecin, Poland.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.